Cencora, Inc. $COR Shares Bought by PensionDanmark Pensionsforsikringsaktieselskab

PensionDanmark Pensionsforsikringsaktieselskab lifted its position in Cencora, Inc. (NYSE:COR) by 6.1% during the second quarter, Holdings Channel reports. The institutional investor owned 31,334 shares of the company’s stock after buying an additional 1,801 shares during the quarter. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Cencora were worth $8,867,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of COR. T. Rowe Price Investment Management Inc. boosted its stake in Cencora by 160.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,700,091 shares of the company’s stock valued at $2,262,956,000 after buying an additional 4,123,795 shares in the last quarter. Norges Bank bought a new stake in Cencora in the fourth quarter worth about $822,506,000. Marshall Wace LLP raised its position in Cencora by 518.9% in the third quarter. Marshall Wace LLP now owns 1,995,118 shares of the company’s stock worth $623,534,000 after acquiring an additional 1,672,762 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Cencora by 528.9% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,475,859 shares of the company’s stock valued at $461,250,000 after acquiring an additional 1,241,186 shares during the last quarter. Finally, Viking Global Investors LP lifted its holdings in Cencora by 95.0% in the 2nd quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock valued at $624,207,000 after acquiring an additional 1,013,913 shares during the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analyst Upgrades and Downgrades

COR has been the topic of several recent research reports. Robert W. Baird set a $370.00 price objective on shares of Cencora in a research note on Thursday. Citigroup reissued a “buy” rating on shares of Cencora in a research note on Thursday. William Blair started coverage on shares of Cencora in a report on Tuesday, April 28th. They set a “market perform” rating for the company. UBS Group upped their price target on Cencora from $412.00 to $430.00 and gave the company a “buy” rating in a report on Thursday. Finally, Barclays cut their price objective on Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, June 10th. Thirteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Cencora currently has an average rating of “Moderate Buy” and a consensus target price of $368.92.

Cencora Price Performance

NYSE COR opened at $320.62 on Friday. The company has a current ratio of 0.93, a quick ratio of 0.59 and a debt-to-equity ratio of 3.53. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The company has a market cap of $62.38 billion, a PE ratio of 23.82, a PEG ratio of 1.84 and a beta of 0.57. The stock’s 50-day moving average price is $293.89 and its two-hundred day moving average price is $314.42.

Cencora (NYSE:COR) last released its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, topping the consensus estimate of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The business had revenue of $84.75 billion for the quarter, compared to the consensus estimate of $84.31 billion. During the same period last year, the firm posted $4.00 earnings per share. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. On average, analysts predict that Cencora, Inc. will post 17.83 EPS for the current year.

Cencora Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, August 14th. Cencora’s payout ratio is 17.83%.

Cencora announced that its Board of Directors has initiated a stock repurchase program on Thursday, May 21st that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to purchase up to 3.9% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its shares are undervalued.

Insider Activity

In other Cencora news, Director Lauren M. Tyler bought 550 shares of Cencora stock in a transaction dated Monday, June 22nd. The stock was bought at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the acquisition, the director directly owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.38% of the stock is owned by insiders.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.